** Shares of medical device maker Becton Dickinson BDX.N fall as much as 13.5% to an eight-year low of $179.09
** Stock set for its worst day since 1999, if losses hold
** BDX cuts annual profit forecast in anticipation of a potential hit from U.S. President Donald Trump's tariffs
** Co said it anticipates a $90 million impact from tariffs expense on China, majority of which will be weighted in Q4
** Co intends to invest $2.5 billion in U.S. manufacturing capacity over the next 5 years
** BDX, which has footprint in Mexico, Europe and Asia, will transfer its manufacturing facilities from China to South Carolina and Nebraska, CEO Thomas Polen said in a conference call
** Co expects its 2025 profit per share to be between $14.06 and $14.34, compared with $14.30 to $14.60 previously expected
** Co reports Q2 adj profit of $3.35 per share, beating estimates of $3.28
** As of last close, BDX had fallen 20.8% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。